Stock Scorecard



Stock Summary for Alphatec Holdings Inc (ATEC) - $16.45 as of 1/13/2026 8:48:10 PM EST

Total Score

5 out of 30

Safety Score

40 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ATEC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ATEC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ATEC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ATEC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ATEC (40 out of 100)

Stock Price Rating (Max of 10) 6
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ATEC

Does Alphatec (ATEC) Pairing With OsteoAdapt Quietly Redraw Its Spine Biologics Investment Narrative? 1/13/2026 6:58:00 AM
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion 1/12/2026 8:27:00 PM
Director’s Massive Share Sale Creates Stir at Alphatec Holdings 1/12/2026 8:27:00 PM
At US$22.65, Is Alphatec Holdings, Inc. (NASDAQ:ATEC) Worth Looking At Closely? 1/12/2026 8:27:00 PM
Alphatec stock tumbles after disappointing 2026 guidance 1/12/2026 5:27:00 PM
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook 1/12/2026 2:27:00 PM
Alphatec Holdings, Inc. Announces Preliminary 2025 Financial Results and 2026 Outlook 1/12/2026 2:27:00 PM
Theradaptive, Inc. announced that it expects to receive funding from Alphatec Holdings, Inc. 1/11/2026 11:57:00 PM
Alphatec Holdings stock hits 52-week high at 22.66 USD 1/9/2026 3:11:00 PM
Alphatec Holdings stock hits 52-week high at 22.66 USD By Investing.com 1/9/2026 2:15:00 PM

Financial Details for ATEC

Company Overview

Ticker ATEC
Company Name Alphatec Holdings Inc
Country USA
Description Alphatec Holdings, Inc. (ATEC), headquartered in Carlsbad, California, is an innovative medical technology firm specializing in the development and commercialization of advanced spinal surgical solutions. The company is dedicated to enhancing patient outcomes through a comprehensive range of products tailored for various spinal disorders, backed by a significant focus on research and development. With a robust pipeline of cutting-edge technologies, Alphatec is well-positioned to capitalize on the growing demand in the orthopedic device sector, making it an attractive investment prospect for institutional investors seeking exposure to the dynamic health tech market.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date 2/25/2026

Stock Price History

Last Day Price 16.45
Price 4 Years Ago 12.35
Last Day Price Updated 1/13/2026 8:48:10 PM EST
Last Day Volume 8,667,582
Average Daily Volume 2,411,329
52-Week High 23.29
52-Week Low 8.81
Last Price to 52 Week Low 86.72%

Valuation Measures

Trailing PE N/A
Industry PE 56.69
Sector PE 123.98
5-Year Average PE -118.17
Free Cash Flow Ratio 15.67
Industry Free Cash Flow Ratio 27.72
Sector Free Cash Flow Ratio 29.04
Current Ratio Most Recent Quarter 1.99
Total Cash Per Share 1.05
Book Value Per Share Most Recent Quarter 0.08
Price to Book Ratio 292.43
Industry Price to Book Ratio 4.82
Sector Price to Book Ratio 24.69
Price to Sales Ratio Twelve Trailing Months 3.59
Industry Price to Sales Ratio Twelve Trailing Months 4.22
Sector Price to Sales Ratio Twelve Trailing Months 19.33
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 148,550,000
Market Capitalization 2,443,647,500
Institutional Ownership 73.84%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.43%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 13.14%
Reported EPS 12 Trailing Months -1.04
Reported EPS Past Year -0.04
Reported EPS Prior Year -0.97
Net Income Twelve Trailing Months -154,961,000
Net Income Past Year -162,123,000
Net Income Prior Year -186,638,000
Quarterly Revenue Growth YOY 30.40%
5-Year Revenue Growth 40.07%
Operating Margin Twelve Trailing Months -4.79%

Balance Sheet

Total Cash Most Recent Quarter 155,741,000
Total Cash Past Year 138,840,000
Total Cash Prior Year 220,970,000
Net Cash Position Most Recent Quarter -339,276,000
Net Cash Position Past Year -435,682,000
Long Term Debt Past Year 574,522,000
Long Term Debt Prior Year 511,035,000
Total Debt Most Recent Quarter 495,017,000
Equity to Debt Ratio Past Year 0.02
Equity to Debt Ratio Most Recent Quarter 0.02
Total Stockholder Equity Past Year 9,434,000
Total Stockholder Equity Prior Year 101,719,000
Total Stockholder Equity Most Recent Quarter 11,506,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -14,000
Free Cash Flow Per Share Twelve Trailing Months 0.00
Free Cash Flow Past Year -137,787,000
Free Cash Flow Prior Year -165,460,000

Options

Put/Call Ratio 2.10
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.47
MACD Signal 0.37
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 1.02
RSI 55.54
50-Day SMA 14.24
150-Day SMA 12.92
200-Day SMA 12.16

System

Modified 1/13/2026 5:48:37 PM EST